Previous 10 | Next 10 |
2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
Paragon 28, Inc. (NYSE: FNA), is thrilled to announce the launch of the Grappler ® Knotless Anchor System and Bridgeline™ Tape, enhancing the Company’s position in the fast-growing foot and ankle specific soft tissue market in 2024 and beyond. Both the Grappler ® K...
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 202...
2023-12-08 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-03 17:58:12 ET More on Novo Nordisk, Stryker, etc. Why Stryker Is An Awesome Healthcare Compounder Stryker Corporation (SYK) 6th Annual Evercore ISI HealthCONx Conference (Transcript) Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation N...
Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its BEAST™ Cortical Fibers which provide an osteoinductive porous structure for cellular attachment and an osteoinductive potential to aid in cellular differentiation and bone formation. These loose cortical fibers are engin...
Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its JAWS™ Great White Staple System which was developed to provide for increased strength and stability of the osteotomy or fusion site when compared to traditional staple systems. The staples feature an ultra-low-profile br...
Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a second trailer to its nationwide mobile lab training program making it even more convenient for the company to facilitate on-site surgeon training and education. Paragon 28’s new mobile lab is housed in a 40 foot tractor...
2023-11-13 10:43:01 ET More on Paragon 28 Seeking Alpha’s Quant Rating on Paragon 28 Historical earnings data for Paragon 28 Financial information for Paragon 28 For further details see: Paragon 28 says DaCosta buys 30.5K shares in the co through i...
2023-11-11 12:32:05 ET Paragon 28, Inc. (FNA) Q3 2023 Earnings Conference Call November 7, 2023, 4:30 PM ET Company Participants Matthew Brinckman - Senior Vice President, Strategy and IR Albert DaCosta - Chairman and CEO Steve Deitsch - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
Paragon 28 Inc. Company Name:
FNA Stock Symbol:
NYSE Market:
2024-06-11 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-11 02:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or "Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance. F...